1011 — China NT Pharma Co Balance Sheet
0.000.00%
- HK$552.88m
- HK$895.84m
- CNY37.96m
Annual balance sheet for China NT Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7.69 | 9.44 | 5.93 | 1.52 | 9.62 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 26 | 12.5 | 33.7 | 10.1 | 0 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 577 | 268 | 73.4 | 12.3 | 16.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 538 | 248 | 380 | 0.944 | 0.543 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,295 | 955 | 1,006 | 329 | 334 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,156 | 896 | 1,170 | 665 | 725 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,279 | 1,167 | 1,247 | 669 | 733 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 16.3 | -211 | -242 | -340 | -399 |
| Total Liabilities & Shareholders' Equity | 1,295 | 955 | 1,006 | 329 | 334 |
| Total Common Shares Outstanding |